Alteration of TEAD1 Expression Levels Confers Apoptotic Resistance through the Transcriptional Up-Regulation of Livin

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Landin Malt, André ^a   Cagliero, Julie ^a   Legent, Kevin ^a   Silber, Joël ^a   Zider, Alain ^a   Flagiello, Domenico ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN 1; LIVIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TEAD1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; FIBROBLAST; GENE SILENCING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STEM CELL; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALTERNATIVE SPLICING; APOPTOSIS; CELL LINE; DNA-BINDING PROTEINS; EPISTASIS, GENETIC; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; RNA ISOFORMS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 84866699136     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045498     Document Type: Article

References (69)

1. Hwang JJ, Chambon P, Davidson I, (1993) Characterization of the transcription activation function and the DNA binding domain of transcriptional enhancer factor-1. Embo J 12: 2337-2348.
2. Anbanandam A, Albarado DC, Nguyen CT, Halder G, Gao X, et al. (2006) Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain. Proc Natl Acad Sci U S A 103: 17225-17230.
3. Burglin TR, (1991) The TEA domain: a novel, highly conserved DNA-binding motif. Cell 66: 11-12.
4. Jacquemin P, Hwang JJ, Martial JA, Dolle P, Davidson I, (1996) A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain. J Biol Chem 271: 21775-21785.
5. Jacquemin P, Sapin V, Alsat E, Evain-Brion D, Dolle P, et al. (1998) Differential expression of the TEF family of transcription factors in the murine placenta and during differentiation of primary human trophoblasts in vitro. Dev Dyn 212: 423-436.
6. Campbell SD, Duttaroy A, Katzen AL, Chovnick A, (1991) Cloning and characterization of the scalloped region of Drosophila melanogaster. Genetics 127: 367-380.
7. Halder G, Polaczyk P, Kraus ME, Hudson A, Kim J, et al. (1998) The Vestigial and Scalloped proteins act together to directly regulate wing-specific gene expression in Drosophila. Genes Dev 12: 3900-3909.
8. Simmonds AJ, Liu X, Soanes KH, Krause HM, Irvine KD, et al. (1998) Molecular interactions between Vestigial and Scalloped promote wing formation in Drosophila. Genes Dev 12: 3815-3820.
9. Xiao JH, Davidson I, Matthes H, Garnier JM, Chambon P, (1991) Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 65: 551-568.
10. Goulev Y, Fauny JD, Gonzalez-Marti B, Flagiello D, Silber J, et al. (2008) SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr Biol 18: 435-441.
11. Wu S, Liu Y, Zheng Y, Dong J, Pan D, (2008) The TEAD/TEF Family Protein Scalloped Mediates Transcriptional Output of the Hippo Growth-Regulatory Pathway. Dev Cell.
12. Zhang L, Ren F, Zhang Q, Chen Y, Wang B, et al. (2008) The TEAD/TEF Family of Transcription Factor Scalloped Mediates Hippo Signaling in Organ Size Control. Dev Cell.
13. Zhao B, Ye X, Yu J, Li L, Li W, et al. (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971.
14. Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML, (2001) TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev 15: 1229-1241.
15. Cao X, Pfaff SL, Gage FH, (2008) YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev 22: 3320-3334.
16. Sawada A, Kiyonari H, Ukita K, Nishioka N, Imuta Y, et al. (2008) Redundant roles of Tead1 and Tead2 in notochord development and the regulation of cell proliferation and survival. Mol Cell Biol 28: 3177-3189.
17. Huang J, Wu S, Barrera J, Matthews K, Pan D, (2005) The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122: 421-434.
18. Zhao B, Lei QY, Guan KL, (2008) The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 20: 638-646.
19. Dong J, Feldmann G, Huang J, Wu S, Zhang N, et al. (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133.
20. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, et al. (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17: 2054-2060.
21. Zhao B, Wei X, Li W, Udan RS, Yang Q, et al. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747-2761.
22. Nolo R, Morrison CM, Tao C, Zhang X, Halder G, (2006) The bantam microRNA is a target of the hippo tumor-suppressor pathway. Curr Biol 16: 1895-1904.
23. Thompson BJ, Cohen SM, (2006) The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell 126: 767-774.
24. Stocker H, (2011) Growth control: Myc and Yorkie get connected. Curr Biol 21: R37-39.
25. Ziosi M, Baena-Lopez LA, Grifoni D, Froldi F, Pession A, et al. (2010) dMyc functions downstream of Yorkie to promote the supercompetitive behavior of hippo pathway mutant cells. PLoS Genet 6.
26. Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, et al. (2001) Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem 276: 15164-15173.
27. Basu S, Totty NF, Irwin MS, Sudol M, Downward J, (2003) Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 11: 11-23.
28. Miller LK, (1999) An exegesis of IAPs: salvation and surprises from BIR motifs. Trends Cell Biol 9: 323-328.
29. Deveraux QL, Reed JC, (1999) IAP family proteins-suppressors of apoptosis. Genes Dev 13: 239-252.
30. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC, (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16: 6914-6925.
31. Richter BW, Duckett CS, (2000) The IAP proteins: caspase inhibitors and beyond. Sci STKE 2000: pe1.
32. Hay BA, Wassarman DA, Rubin GM, (1995) Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death. Cell 83: 1253-1262.
33. Knight JF, Shepherd CJ, Rizzo S, Brewer D, Jhavar S, et al. (2008) TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. Br J Cancer 99: 1849-1858.
34. Hucl T, Brody JR, Gallmeier E, Iacobuzio-Donahue CA, Farrance IK, et al. (2007) High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor dependent MCAT motif. Cancer Res 67: 9055-9065.
35. Gluck S, Ross JS, Royce M, McKenna EF Jr, Perou CM, et al., editors. TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine +/- trastuzumab. Breast Cancer Res Treat.
36. Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, et al. (2005) Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 11: 4044-4055.
37. Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, et al. (2005) Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 11: 7012-7022.
38. Fossdal R, Jonasson F, Kristjansdottir GT, Kong A, Stefansson H, et al. (2004) A novel TEAD1 mutation is the causative allele in Sveinsson's chorioretinal atrophy (helicoid peripapillary chorioretinal degeneration). Hum Mol Genet 13: 975-981.
39. Kitagawa M, (2007) A Sveinsson's chorioretinal atrophy-associated missense mutation in mouse Tead1 affects its interaction with the co-factors YAP and TAZ. Biochem Biophys Res Commun 361: 1022-1026.
40. Ota M, Sasaki H, (2008) Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 135: 4059-4069.
41. Scarlett JL, Sheard PW, Hughes G, Ledgerwood EC, Ku HH, et al. (2000) Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett 475: 267-272.
42. Walker PR, Leblanc J, Carson C, Ribecco M, Sikorska M, (1999) Neither caspase-3 nor DNA fragmentation factor is required for high molecular weight DNA degradation in apoptosis. Ann N Y Acad Sci 887: 48-59.
43. Maeda T, Chapman DL, Stewart AF, (2002) Mammalian Vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation. J Biol Chem 9: 9.
44. Gunther S, Mielcarek M, Kruger M, Braun T, (2004) VITO-1 is an essential cofactor of TEF1-dependent muscle-specific gene regulation. Nucleic Acids Res 32: 791-802.
45. Ashhab Y, Alian A, Polliack A, Panet A, Ben Yehuda D, (2001) Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett 495: 56-60.
46. Crnkovic-Mertens I, Semzow J, Hoppe-Seyler F, Butz K, (2006) Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells. J Mol Med 84: 232-240.
47. Cowell IG, Okorokov AL, Cutts SA, Padget K, Bell M, et al. (2000) Human topoisomerase IIalpha and IIbeta interact with the C-terminal region of p53. Exp Cell Res 255: 86-94.
48. Yu L, Wang Z, (2009) Effects of Livin gene RNA interference on apoptosis of cervical cancer Hela cells and enhanced sensitivity to cisplatin. J Huazhong Univ Sci Technolog Med Sci 29: 625-630.
49. Kasof GM, Gomes BC, (2001) Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 276: 3238-3246.
50. Yan B, Kong M, Chen S, Chen YH, (2010) VEGF stimulation enhances Livin protein synthesis through mTOR signaling. J Cell Biochem 111: 1114-1124.
51. Dynek JN, Chan SM, Liu J, Zha J, Fairbrother WJ, et al. (2008) Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. Cancer Res 68: 3124-3132.
52. Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y, (1999) A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. Embo J 18: 2551-2562.
53. Milewski RC, Chi NC, Li J, Brown C, Lu MM, et al. (2004) Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3. Development 131: 829-837.
54. Strano S, Monti O, Pediconi N, Baccarini A, Fontemaggi G, et al. (2005) The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. Mol Cell 18: 447-459.
55. Li Z, Zhao B, Wang P, Chen F, Dong Z, et al. (2010) Structural insights into the YAP and TEAD complex. Genes Dev 24: 235-240.
56. Stewart AF, Larkin SB, Farrance IK, Mar JH, Hall DE, et al. (1994) Muscle-enriched TEF-1 isoforms bind M-CAT elements from muscle-specific promoters and differentially activate transcription. J Biol Chem 269: 3147-3150.
57. Xu X, Xing S, Du ZQ, Rothschild MF, Yerle M, et al. (2008) Porcine TEF1 and RTEF1: molecular characterization and association analyses with growth traits. Comp Biochem Physiol B Biochem Mol Biol 150: 447-453.
58. Maeda T, Chapman DL, Stewart AF, (2002) Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation. J Biol Chem 277: 48889-48898.
59. Maeda T, Gupta MP, Stewart AF, (2002) TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. Biochem Biophys Res Commun 294: 791-797.
60. Chen Z, Friedrich GA, Soriano P, (1994) Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev 8: 2293-2301.
61. Tsika RW, Ma L, Kehat I, Schramm C, Simmer G, et al. (2010) TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction. J Biol Chem 285: 13721-13735.
62. Yang X, Li DM, Chen W, Xu T, (2001) Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G(2)/M arrest or apoptosis. Oncogene 20: 6516-6523.
63. Aylon Y, Michael D, Shmueli A, Yabuta N, Nojima H, et al. (2006) A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev 20: 2687-2700.
64. Song T, Hong BF, Gao JP, Zhang L, Cai W, (2008) [Expression of apoptosis inhibitor gene Livin in prostate cancer and its clinical implication]. Zhonghua Nan Ke Xue 14: 30-33.
65. Ye L, Song X, Li S, Yang D, Zhang J, et al. (2011) Livin-alpha promotes cell proliferation by regulating G1-S cell cycle transition in prostate cancer. Prostate 71: 42-51.
66. Pobbati AV, Chan SW, Lee I, Song H, Hong W, (2012) Structural and Functional Similarity between the Vgll1-TEAD and the YAP-TEAD Complexes. Structure 20: 1135-1140.
67. Legent K, Mas M, Dutriaux A, Bertrandy S, Flagiello D, et al. (2006) In vivo analysis of Drosophila deoxyribonucleoside kinase function in cell cycle, cell survival and anti-cancer drugs resistance. Cell Cycle 5: 740-749.
68. Kessler DS, (1997) Siamois is required for formation of Spemann's organizer. Proc Natl Acad Sci U S A 94: 13017-13022.
69. Barbieri G, Deffrennes V, Prod'homme T, Vedrenne J, Baton F, et al. (2002) Isoforms of the class II transactivator protein. Int Immunol 14: 839-848.